Apogee Therapeutics Inc.

AI Score

0

Unlock

40.41
1.07 (2.72%)
At close: Jan 15, 2025, 1:41 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22
Net Income -83.98M -39.78M
Depreciation & Amortization n/a n/a
Stock-Based Compensation 6.10M 2.14M
Other Working Capital 4.49M 9.40M
Other Non-Cash Items -2.98M 11.40M
Deferred Income Tax n/a n/a
Change in Working Capital 6.11M 9.81M
Operating Cash Flow -74.76M -16.43M
Capital Expenditures -167.00K n/a
Acquisitions n/a n/a
Purchase of Investments -303.74M n/a
Sales Maturities Of Investments 30.00M n/a
Other Investing Acitivies n/a n/a
Investing Cash Flow -273.91M n/a
Debt Repayment n/a n/a
Common Stock Repurchased n/a n/a
Dividend Paid n/a n/a
Other Financial Acitivies n/a 168.50M
Financial Cash Flow 315.39M 183.62K
Net Cash Flow -33.28M -16.24M
Free Cash Flow -74.93M -16.43M